0001367644-21-000044.txt : 20210226
0001367644-21-000044.hdr.sgml : 20210226
20210226171559
ACCESSION NUMBER: 0001367644-21-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Karen L.
CENTRAL INDEX KEY: 0001639637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 21691104
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD
CITY: DUBLIN L2 4
STATE: L2
ZIP: 0
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_161437771751742.xml
FORM 4
X0306
4
2021-02-24
0
0001367644
Emergent BioSolutions Inc.
EBS
0001639637
Smith Karen L.
400 PROFESSIONAL DRIVE, SUITE 400
GAITHERSBURG,
MD
20879
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2021-02-24
4
A
0
2942
0
A
9252
D
Common Stock
2021-02-24
4
A
0
2941
0
A
12193
D
Employee Stock Options (Right to Buy)
93.49
2021-02-24
4
A
0
11765
93.49
A
2028-02-23
Common Stock
11765.0
11765
D
Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
/s/ S. Scott Lieberman, Attorney-in-fact
2021-02-26